<DOC>
	<DOCNO>NCT02034812</DOCNO>
	<brief_summary>This clinical utility study base review real de-identified randomize patient case aim evaluate radiation oncologist 's treatment recommendation review result provide Decipher test . The primary intent help guide development design future clinical utility study Decipher .</brief_summary>
	<brief_title>Decision Impact Study Measure Influence DECIPHER Treatment Recommendations Radiation Oncologists</brief_title>
	<detailed_description>Patient case select use exist data generate patient specimen collect separate IRB approve protocol , pathological specimen test generate test result comparison outcome . Those test result present study , individual patient outcome . Physicians participate current study provide care subject previous study . Cases present physician randomize order form prevent patient identify , directly indirectly . High risk patient case select reflect range clinicopathological variable stratify base Decipher predict probability develop metastasis 5 year RP 3 year BCR ( show table ) . High ( low ) Decipher ( GC ) risk define 5- 3-year predict probability metastasis great ( less ) 6 % adjuvant setting great ( less ) 18 % salvage setting .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Case Patient case eligible study treat radical prostatectomy one adverse pathological feature present define : Pathological Gleason score â‰¥ 8 Gleason score 7 primary pattern 4 ; Pathological stage T3a ( = Extracapsular extension ) T3b ( =Seminal vesicle invasion ) ; Positive surgical margin Gleason grade upgrade biopsy surgery Detectable PSA , define failure PSA fall undetectable , PSA detectable rise 2 subsequent determination Case Metastatic disease ( M+ ) prior surgery Received neoadjuvant prostate cancer treatment prior radical prostatectomy ( radiation , hormone , chemotherapy )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>